|
US2019298733A1
|
|
Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
|
|
US2019015404A1
|
|
Kinase inhibitors for treatment of disease
|
|
CA2974781A1
|
|
Rho kinase inhibitor ba-1049 (r) and active metabolites thereof
|
|
US2020032268A1
|
|
TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS
|
|
US2017246181A1
|
|
Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
|
|
EP3558314A1
|
|
Rho kinase inhibitor ba-1049 (r) and active metabolites thereof
|
|
US2017313680A1
|
|
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
|
|
US2016213664A1
|
|
Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors
|
|
US2015297643A1
|
|
Inhibition of rho and or rock and cell transplantation
|
